uniQure N.V. - Ordinary Shares (QURE): Price and Financial Metrics


uniQure N.V. - Ordinary Shares (QURE)

Today's Latest Price: $60.64 USD

2.95 (-4.64%)

Updated Feb 21 4:00pm

Add QURE to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 338 in Biotech

See all "A" rated Strong Buy stocks

QURE Stock Summary

  • With a price/sales ratio of 484.39, uniQure NV has a higher such ratio than 99.28% of stocks in our set.
  • With a year-over-year growth in debt of 245.79%, uniQure NV's debt growth rate surpasses 92.91% of about US stocks.
  • Revenue growth over the past 12 months for uniQure NV comes in at -48.91%, a number that bests only 3.78% of the US stocks we're tracking.
  • If you're looking for stocks that are quantitatively similar to uniQure NV, a group of peers worth examining would be CRNX, TOCA, ARQL, ADAP, and CNCE.
  • QURE's SEC filings can be seen here. And to visit uniQure NV's official web site, go to www.uniqure.com.
QURE Daily Price Range
QURE 52-Week Price Range

QURE Stock Price Chart More Charts


QURE Price/Volume Stats

Current price $60.64 52-week high $82.49
Prev. close $63.59 52-week low $36.20
Day low $60.37 Volume 251,100
Day high $63.74 Avg. volume 455,477
50-day MA $66.68 Dividend yield N/A
200-day MA $59.94 Market Cap 2.65B

uniQure N.V. - Ordinary Shares (QURE) Company Bio


uniQure is a biopharmaceutical company, developing adeno-associated virus (AAV) based gene therapies through its technology platform for multiple therapeutic areas. The company was founded in 1998 and is based in Amsterdam, the Netherlands.


QURE Latest News Stream


Event/Time News Detail
Loading, please wait...

QURE Latest Social Stream


Loading social stream, please wait...

View Full QURE Social Stream

QURE Price Returns

1-mo -1.24%
3-mo 16.55%
6-mo 14.14%
1-year 50.58%
3-year 894.10%
5-year 214.69%
YTD -15.38%
2019 148.65%
2018 47.12%
2017 249.82%
2016 -66.14%
2015 11.68%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.658 seconds.